Cargando…
IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
Breast cancer is the most commonly diagnosed cancer in women. Metastasis is the primary cause of mortality for breast cancer patients. Multiple mechanisms underlie breast cancer metastatic dissemination, including the interleukin-6 (IL-6)-mediated signaling pathway. IL-6 is a pleiotropic cytokine th...
Autores principales: | Manore, Sara G., Doheny, Daniel L., Wong, Grace L., Lo, Hui-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964978/ https://www.ncbi.nlm.nih.gov/pubmed/35371975 http://dx.doi.org/10.3389/fonc.2022.866014 |
Ejemplares similares
-
The role of IL-6/JAK2/STAT3 signaling pathway in cancers
por: Huang, Bei, et al.
Publicado: (2022) -
Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis
por: Doheny, Daniel, et al.
Publicado: (2020) -
Hedgehog Signaling and Truncated GLI1 in Cancer
por: Doheny, Daniel, et al.
Publicado: (2020) -
Overexpression of NPTX2 Promotes Malignant Phenotype of Epithelial Ovarian Carcinoma via IL6-JAK2/STAT3 Signaling Pathway Under Hypoxia
por: Han, Xiaotian, et al.
Publicado: (2021) -
“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
por: Bousoik, Emira, et al.
Publicado: (2018)